SIR-Sphere Y-90
SAM.GOV Due: June 9, 2025 at 01:30 PM UTC
In-Active Special Notice Source Url

Summary

The SIR-Sphere Y-90 opportunity is a Special Notice issued by the Defense Health Agency Contracting Activity (DHACA) for the procurement of SIR-Sphere Y-90 resin microspheres, which are utilized in the treatment of unresectable metastatic liver tumors, particularly those stemming from primary colorectal cancer. This procurement is intended for the Nuclear Medicine Department at Walter Reed National Military Medical Center (WRNMMC) and will be awarded as a Firm Fixed Price Blanket Purchase Agreement (BPA) to Sirtex Medical, Inc. The opportunity is not open for competitive bidding, as it is a sole source procurement under FAR 13.5, indicating that only the specified vendor is eligible to fulfill this contract. Contractors with expertise in medical devices, particularly those involved in nuclear medicine and therapeutic imaging, should consider this opportunity.
Description

Notice of Intent for Peripheral Intervention technology identified as SIR-Sphere Y-90, which is a for the treatment of unresectable metastatic liver tumors.

The Defense Health Agency Contracting Activity (DHACA), Northeast Healthcare Contracting Division – Northeast (NCD-NE), on beh

Entities
DOD
Department of Defense
DHA(
Defense Health Agency
NAICS
334517
Set Aside
None
Place of Performance
Gaithersburg , Maryland 20899
Point of Contact
Full Name Email Phone Type
Malcolm Dodson [email protected] primary
Miriam Railey [email protected] secondary